Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Selassie Ogyaadu

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Diabetes Reports|November 4, 2021
Assessing Glycemic Control Using CGM for Women with Diabetes in PregnancyGrenye O'Malley, Ally Wang, Selassie Ogyaadu, et al.
Journal of Diabetes Science and Technology|November 2, 2022
Pilot Study for Use of Intermittently Scanned Continuous Glucose Monitoring in Women with Gestational DiabetesGrenye O'Malley, Dushyanthy Arumugam, Selassie Ogyaadu, et al.
Journal of Diabetes Science and Technology|July 3, 2025
Postpartum Continuous Glucose Monitoring to Detect Dysglycemia After Gestational DiabetesCamila Cabrera, Selassie Ogyaadu, Camilla Levister, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|November 19, 2025
Reproductive Health Counseling in the T1D Exchange Quality Improvement CollaborativeGrenye O'Malley, Selassie Ogyaadu, Camilla Levister, et al.
Diabetes Care|November 19, 2021
Impact of a Novel Diabetes Support System on a Cohort of Individuals With Type 1 Diabetes Treated With Multiple Daily Injections: A Multicenter Randomized StudyAlessandro Bisio, Stacey Anderson, Lisa Norlander, et al.
Science Advances|November 1, 2023
RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetesNagesha Guthalu Kondegowda, Joanna Filipowska, Jeong-Su Do, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Proinflammatory circulating extracellular vesicles from type 1 diabetes patients contribute to beta cell cytotoxicity and disease pathogenicityNagesha Guthalu Kondegowda, Zelda Cisneros, Daniel Roeth, et al.
Journal of the Endocrine Society|May 9, 2024
Concordance of Blood Glucose and CGM During a Pilot Trial of Automated Insulin Delivery in Type 1 Diabetes PregnanciesRavinder Jeet Kaur, Carol J Levy, Kristin Castorino, et al.
Diabetes Technology & Therapeutics|March 1, 2022
Feasibility of Closed-Loop Insulin Delivery with a Pregnancy-Specific Zone Model Predictive Control AlgorithmBasak Ozaslan, Carol J Levy, Yogish C Kudva, et al.
Diabetes Care|May 17, 2023
At-Home Use of a Pregnancy-Specific Zone-MPC Closed-Loop System for Pregnancies Complicated by Type 1 Diabetes: A Single-Arm, Observational Multicenter StudyCarol J Levy, Yogish C Kudva, Basak Ozaslan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Diabetes Reports|November 4, 2021
Assessing Glycemic Control Using CGM for Women with Diabetes in PregnancyGrenye O'Malley, Ally Wang, Selassie Ogyaadu, et al.
Journal of Diabetes Science and Technology|November 2, 2022
Pilot Study for Use of Intermittently Scanned Continuous Glucose Monitoring in Women with Gestational DiabetesGrenye O'Malley, Dushyanthy Arumugam, Selassie Ogyaadu, et al.
Journal of Diabetes Science and Technology|July 3, 2025
Postpartum Continuous Glucose Monitoring to Detect Dysglycemia After Gestational DiabetesCamila Cabrera, Selassie Ogyaadu, Camilla Levister, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|November 19, 2025
Reproductive Health Counseling in the T1D Exchange Quality Improvement CollaborativeGrenye O'Malley, Selassie Ogyaadu, Camilla Levister, et al.
Diabetes Care|November 19, 2021
Impact of a Novel Diabetes Support System on a Cohort of Individuals With Type 1 Diabetes Treated With Multiple Daily Injections: A Multicenter Randomized StudyAlessandro Bisio, Stacey Anderson, Lisa Norlander, et al.
Science Advances|November 1, 2023
RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetesNagesha Guthalu Kondegowda, Joanna Filipowska, Jeong-Su Do, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Proinflammatory circulating extracellular vesicles from type 1 diabetes patients contribute to beta cell cytotoxicity and disease pathogenicityNagesha Guthalu Kondegowda, Zelda Cisneros, Daniel Roeth, et al.
Journal of the Endocrine Society|May 9, 2024
Concordance of Blood Glucose and CGM During a Pilot Trial of Automated Insulin Delivery in Type 1 Diabetes PregnanciesRavinder Jeet Kaur, Carol J Levy, Kristin Castorino, et al.
Diabetes Technology & Therapeutics|March 1, 2022
Feasibility of Closed-Loop Insulin Delivery with a Pregnancy-Specific Zone Model Predictive Control AlgorithmBasak Ozaslan, Carol J Levy, Yogish C Kudva, et al.
Diabetes Care|May 17, 2023
At-Home Use of a Pregnancy-Specific Zone-MPC Closed-Loop System for Pregnancies Complicated by Type 1 Diabetes: A Single-Arm, Observational Multicenter StudyCarol J Levy, Yogish C Kudva, Basak Ozaslan, et al.
Pageof 1